{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:43:57Z","timestamp":1786160637624,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241219"],"award-info":[{"award-number":["82241219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101874"],"award-info":[{"award-number":["82101874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["24JCYBJC01880"],"award-info":[{"award-number":["24JCYBJC01880"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115155","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:16:58Z","timestamp":1751383018000},"page":"115155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Idelalisib modulates CD4+ T cell responses to mitigate rejection of allografts in mice"],"prefix":"10.1016","volume":"162","author":[{"given":"Weiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Iske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqi","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/imr.12038","article-title":"CD4(+) T-cell subsets in transplantation","volume":"252","author":"Liu","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2025.115155_bb0010","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell Allorecognition pathways in solid organ transplantation","volume":"9","author":"Siu","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115155_bb0015","article-title":"A story of kinases and adaptors: the role of Lck, ZAP-70 and LAT in switch panel governing T-cell development and activation","volume":"12","author":"Fern\u00e1ndez-Aguilar","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.intimp.2025.115155_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115155_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718621","article-title":"Strategies to overcome failures in T-cell immunotherapies by targeting PI3K-\u03b4 and -\u03b3","volume":"12","author":"Chandrasekaran","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115155_bb0030","article-title":"mTOR-mediated regulation of immune responses in cancer and tumor microenvironment","volume":"12","author":"Mafi","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115155_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.115155_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-065X.2003.00008.x","article-title":"The PI-3 kinase\/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3","volume":"192","author":"Kane","year":"2003","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2025.115155_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nri2745","article-title":"Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate","volume":"10","author":"Sauer","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115155_bb0050","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026609","article-title":"The PI3K-PKB\/Akt pathway","volume":"7","author":"Hemmings","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115155_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni0403-313","article-title":"The role of PI3K in immune cells","volume":"4","author":"Koyasu","year":"2003","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115155_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.it.2006.12.007","article-title":"Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K","volume":"28","author":"Okkenhaug","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2025.115155_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00001","article-title":"Glucose metabolism regulates T cell activation, differentiation, and functions","volume":"6","author":"Palmer","year":"2015","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2025.115155_bb0070","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1074\/jbc.M114.634683","article-title":"Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase \u03b4","volume":"290","author":"Somoza","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2025.115155_bb0075","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K Delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.115155_bb0080","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115155_bb0085","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","article-title":"PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma","volume":"370","author":"Gopal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.intimp.2025.115155_bb0090","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s40265-014-0285-6","article-title":"Idelalisib: first global approval","volume":"74","author":"Markham","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2025.115155_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661580","article-title":"IL-21 receptor blockade shifts the follicular T cell balance and reduces De Novo donor-specific antibody generation","volume":"12","author":"Nian","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115155_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajt.16218","article-title":"CTLA4-Ig prolongs graft survival specifically in young but not old mice","volume":"21","author":"Heinbokel","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2025.115155_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112955","article-title":"Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-mediated Th1 differentiation in mice","volume":"141","author":"Kong","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115155_bb0110","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115155_bb0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/stem.5530120502","article-title":"The activation antigen CD69","volume":"12","author":"Ziegler","year":"1994","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOT.0b013e32831b70c2","article-title":"Relative roles of Th1 and Th17 effector cells in allograft rejection","volume":"14","author":"Atalar","year":"2009","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2025.115155_bb0125","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/ki.1997.256","article-title":"Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts","volume":"51","author":"D'Elios","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0130","first-page":"25","article-title":"Ki-67, marker of proliferation","volume":"17","author":"Guinebreti\u00e8re","year":"1997","journal-title":"Ann. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115155_bb0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3181b96646","article-title":"Overcoming chronic rejection-can it B","volume":"88","author":"Kwun","year":"2009","journal-title":"Transplantation"},{"issue":"18","key":"10.1016\/j.intimp.2025.115155_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156648","article-title":"Single-cell transcriptome mapping identifies a local, innate B cell population driving chronic rejection after lung transplantation","volume":"7","author":"Smirnova","year":"2022","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.intimp.2025.115155_bb0145","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.168.6.2729","article-title":"CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K\/PKB signaling pathway in primary human T cells","volume":"168","author":"Appleman","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115155_bb0150","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2007-08-108050","article-title":"CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85\/p110 heterodimer","volume":"111","author":"Gar\u00e7on","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115155_bb0155","author":"Pompura"},{"issue":"4","key":"10.1016\/j.intimp.2025.115155_bb0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41422-020-0301-1","article-title":"Signaling networks in immunometabolism","volume":"30","author":"Saravia","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-024-07405-8","article-title":"SGLT2 inhibition improves PI3K\u03b1 inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials","volume":"208","author":"Borrego","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2025.115155_bb0170","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.intimp.2025.115155_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115155_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41581-023-00791-0","article-title":"Translating B cell immunology to the treatment of antibody-mediated allograft rejection","volume":"20","author":"Heeger","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115155_bb0185","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.healun.2021.06.008","article-title":"IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection","volume":"40","author":"Wang","year":"2021","journal-title":"J. Heart Lung Transplant."},{"issue":"12","key":"10.1016\/j.intimp.2025.115155_bb0190","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1111\/ajt.15550","article-title":"A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice","volume":"19","author":"Watanabe","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-016-0343-5","article-title":"Targeting of PI3K\/AKT\/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development","volume":"9","author":"Herrero-S\u00e1nchez","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115155_bb0200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115155_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10214832","article-title":"Old and new Calcineurin inhibitors in lupus nephritis","volume":"10","author":"Ponticelli","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115155_bb0210","first-page":"1","article-title":"Two decades of tacrolimus in renal transplant: basic science and clinical evidences","volume":"15","author":"Shrestha","year":"2017","journal-title":"Exp. Clin. Transplant."},{"issue":"10","key":"10.1016\/j.intimp.2025.115155_bb0215","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/1060028015594813","article-title":"Idelalisib: a novel PI3K\u03b4 inhibitor for chronic lymphocytic leukemia","volume":"49","author":"Shah","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115155_bb0220","article-title":"Safety and efficacy of dual PI3K-\u03b4, \u03b3 inhibitor, duvelisib in patients with relapsed or refractory lymphoid neoplasms: a systematic review and meta-analysis of prospective clinical trials","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:23:56Z","timestamp":1786159436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"alternative-id":["S1567576925011452"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115155","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idelalisib modulates CD4+ T cell responses to mitigate rejection of allografts in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115155"}}